Marta Moretti

10PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersRegenerative medicine (incl. stem cells)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Dec 18, 2024
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation.

Fabio Bordin, Gloria Terriaca, Adriano Apostolico

|Dec 07, 2023
SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma.

Ludovica Lospinoso Severini, Elena Loricchio, Shirin Navacci

|Sep 11, 2021
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.

Stefano Di Giulio, Valeria Colicchia, Fabio Pastorino

Pageof 2